Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by QueenNerfertition Jun 27, 2017 3:17pm
320 Views
Post# 26410284

Q1 PROJECTIONS

Q1 PROJECTIONS

Price per gram sold is rising as value added goods hit the store. Craftgrow also effectively increases this as well. Using $8.03 as a base for Q1 sales we can put some rough numbers together. 

This morning Bruce suggested that the company is selling 0.7g/patient/day. This seems high, GoBlue pinned Q4 around 0.4 and competitors are selling at 0.5 (all lower than HC stats which is currently at 0.75). We will use 0.5g/patient/day.

Patient onboarding for Q1 was slow with the Q starting at 56,000 and will be ending just above 58,000. 

$8.03 * 57,000 * 0.5 * 90 = $20.6mm

This is only accounting for their domestic retail business as well as no sales from Craft Grow. 

If we use Bruce's 0.7, we come to over $28mm for the quarter. We will be able to hold him to those claims in 7 weeks from now. 

Feel free to add/discuss. 

 

Prospective Wiz Queen

Bullboard Posts